Prot #U31402-A-U201: HERTHENA-Lung01: A Phase 2 Randomized Open-Label Study of Patritumab Deruxtecan (U3-1402) in Subjects with Previously Treated Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer (NSCLC)

Project: Research project

Project Details

StatusActive
Effective start/end date4/9/214/9/24

Funding

  • INC Research, LLC (Prot #U31402-A-U201)
  • Daiichi Sankyo, Inc. (Prot #U31402-A-U201)